Azilsartan (medoxomil monopotassium)

Overview

Azilsartan medoxomil (TAK 491) monopotassium, a prodrug form of Azilsartan ( HY-14914 ), is an orally active angiotensin II receptor type 1 antagonist. Azilsartan medoxomil monopotassium can be used for the study of essential hypertension.

Application

Products | Products > Disease Areas > Urogenital Cancer | Products > Disease Areas > Hypertension | Products > Disease Areas > Cancer | Products > Disease Areas > Blood or Cardio-cerebrovascular Disease | Products > Disease Areas > Urogenital Disease | Products > Disease Areas > Metabolic or Endocrine Disease | Products > Disease Areas > Cardiovascular Disease | Products > Disease Areas > Prostate Cancer | Products > Signaling Pathways > GPCR/G Protein | Products > Research Areas > Metabolic Disease | Products > Research Areas > Cardiovascular Disease | Products > Research Areas > Cancer | Products > Research Areas > Cancer > Cancer Targeted Therapy | Products > Research Areas > Cancer > Cancer Metabolism and Metastasis | Products > Signaling Pathways > Angiotensin Receptor

Product Information

• Catalog No.: HY-17458
• CAS No.: 863031-24-7
• Molecular Formula: C30H23KN4O8
• Molecular Weight: 606.62
• Purity: 98.00%
• Storage: 4°C, sealed storage, away from moisture * In solvent : -80°C, 6 months; -20°C, 1 month (sealed storage, away from moisture)
• Solubility: ≥ 3 mg/mL (4.95 mM); Clear solution
• Availability: In-stock

Source

Original product source